Biomedical Engineering Reference
In-Depth Information
99. Perez-Tenorio, G., and Stal, O. Activation of AKT/PKB in breast cancer
predicts a worse outcome among endocrine treated patients.
Br J
, 540-545 (2002).
100. Hurtado, A.,
Cancer
86
Regulation of ERBB2 by oestrogen receptor-PAX2
determines response to tamoxifen.
et al.
Nature
456
, 663-666 (2008).
101. Johnston, S.,
Lapatinib combined with letrozole versus letrozole
and placebo as first-line therapy for postmenopausal hormone
receptor-positive metastatic breast cancer.
et al.
J Clin Oncol
27
, 5538-5546
(2009).
102. Kaufman, B.,
Trastuzumab plus anastrozole versus anastrozole
alone for the treatment of postmenopausal women with human
epidermal growth factor receptor 2-positive, hormone receptor-
positive metastatic breast cancer: results from the randomized phase
III TAnDEM study.
et al.
J Clin Oncol
27
, 5529-5537 (2009).
103. Pritchard, K.I.,
Randomized trial of tamoxifen versus combined
tamoxifen and octreotide LAR therapy in the adjuvant treatment of
early-stage breast cancer in postmenopausal women: NCIC CTG MA.14.
J Clin Oncol
et al.
, 3869-3876 (2011).
104. Mendes-Pereira, A.M.,
29
Breast Cancer Special Feature: Genome-
wide functional screen identifies a compendium of genes affecting
sensitivity to tamoxifen.
et al.
(2012).
105. Wittliff, J.L., Fisher, B., and Durant, J.R. Establishment of uniformity in
steroid receptor analyses used in cooperative clinical trials of breast
cancer treatment.
Proc Natl Acad Sci U S A
, 198-206 (1980).
106. Wittliff, J.L., Brown, A.M., and Fisher, B. Establishment of uniformity
in steroid receptor determinations for protocol B-09 of the National
Surgical Adjuvant Breast Project in
Recent Results Cancer Res
71
Estrogen receptor assays in breast
cancer: laboratory discrepancies and quality assurance
(eds. Sarfaty,
G.A., Nash, A.R. & Keightley, D.D.) (New York (NY): Masson Publishing
USA, 1981).
107. Hull, D.F., 3
rd
,
et al.
Multiple estrogen receptor assays in human breast
, 413-416 (1983).
108. Pasic, R., Djulbegovic, B., and Wittliff, J.L. Comparison of sex steroid
receptor
cancer.
Cancer Res
43
determinations
in
human
breast
cancer
by
enzyme
immunoassay and radioligand binding.
J Clin Lab Anal
4
, 430-436
(1990).
109. King, W.J., and Greene, G.L. Monoclonal antibodies localize oestrogen
receptor in the nuclei of target cells.
Nature
307
, 745-747 (1984).
